Pinnacle Wealth Management Advisory Group’s Acumen Pharmaceuticals ABOS Stock Holding History

Pinnacle Wealth Management Advisory Group’s Portfolio ABOS Stock Details ABOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$40K	Buy	18,021 +1	+0%	+$3	﹤0.01%	546
2026 Q2	$48.1K	Hold	18,020	–	–	﹤0.01%	560
2026 Q1	$42.5K	Hold	18,020	–	–	﹤0.01%	538
2025 Q4	$38K	Hold	18,020	–	–	﹤0.01%	518
2025 Q3	$30.8K	Hold	18,020	–	–	﹤0.01%	395
2025 Q2	$20.9K	Hold	18,020	–	–	﹤0.01%	366
2025 Q1	$19.8K	Hold	18,020	–	–	﹤0.01%	358
2024 Q4	$31K	Hold	18,020	–	–	﹤0.01%	354
2024 Q3	$44.7K	Hold	18,020	–	–	﹤0.01%	357
2024 Q2	$43.6K	Hold	18,020	–	–	﹤0.01%	346
2024 Q1	$73K	Buy	+18,020	New	+$67.9K	0.01%	342
2023 Q4	–	Sell	-18,020	Closed	-$74.8K	–	339
2023 Q3	$74.8K	Hold	18,020	–	–	0.01%	307
2023 Q2	$86.7K	Buy	+18,020	New	+$86.3K	0.01%	320

Other funds holding ABOS

Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return

Clune & Associates Chicago, Illinois $654M AUM 13.19% 1-Year Est. Return

TFC Financial Management Boston, Massachusetts $893M AUM 15.25% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Parkside Financial Bank & Trust Saint Louis, Missouri $1.51B AUM 17.86% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

SJS Investment Consulting Sylvania, Ohio $993M AUM 16.29% 1-Year Est. Return

Pinnacle Wealth Management Advisory Group's ABOS Position: Q3 2026 in Review

Pinnacle Wealth Management Advisory Group increased its Acumen Pharmaceuticals (ABOS) stake by 0.01% in Q3 2026, buying an estimated $3 and bringing the position to 18,021 shares worth $40K. The position accounts for ﹤0.01% of the portfolio, ranked #546.

Pinnacle Wealth Management Advisory Group first reported a position in ABOS in Q2 2023 and has held it in 13 quarters since. The position peaked at $86.7K in Q2 2023. 11 funds tracked by Wall St. Rank hold ABOS as of Q3 2026.

Pinnacle Wealth Management Advisory Group held 18,021 shares of Acumen Pharmaceuticals worth $40K as of Q3 2026.
Pinnacle Wealth Management Advisory Group bought 1 Acumen Pharmaceuticals share in Q3 2026, an estimated $3.
Acumen Pharmaceuticals made up ﹤0.01% of Pinnacle Wealth Management Advisory Group's portfolio in Q3 2026, its #546 holding.
Pinnacle Wealth Management Advisory Group first reported a position in Acumen Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
Pinnacle Wealth Management Advisory Group's Acumen Pharmaceuticals position peaked at $86.7K in Q2 2023.
11 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q3 2026.

Based on Pinnacle Wealth Management Advisory Group's 13F filing for Q3 2026, filed 23 Oct 2026.